<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3097">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04344509</url>
  </required_header>
  <id_info>
    <org_study_id>PAVM COVID</org_study_id>
    <nct_id>NCT04344509</nct_id>
  </id_info>
  <brief_title>Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients</brief_title>
  <official_title>Microbial Etiology of Ventilator-associated Pneumonia (VAP) in COVID-19 Infected Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      National multicentric observational retrospective case-control study comparing the relative
      frequency of the various microorganisms responsible for VAP in patients infected or not by
      SARS-CoV-2 and their resistance to antibiotics.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of the microorganisms responsible for VAP among patients infected or not by the SARS-CoV-2</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of multi-drug resistant bacteria responsible for VAP among patients infected or not by the SARS-CoV-2</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>COVID19-positive patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID19-negative patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bacterial species isolated</intervention_name>
    <description>in the respiratory specimen</description>
    <arm_group_label>COVID19-negative patients</arm_group_label>
    <arm_group_label>COVID19-positive patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with microbiologically confirmed VAP with pulmonary samples collected from
        March 15 to April 15 in France.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with microbiologically confirmed VAP with pulmonary samples collected
             from March 15 to April 15 in France.

        Exclusion Criteria:

          -  All patients with microbiologically confirmed VAP with pulmonary samples collected
             from March 15 to April 15 in France.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe BURUCOA</last_name>
    <phone>549443889</phone>
    <phone_ext>+33</phone_ext>
    <email>christophe.burucoa@chu-poitiers.fr</email>
  </overall_contact>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

